Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II Study of HJ787 Ointment in Mild to Moderate Atopic Dermatitis
CTR20242529Phase 2Active
- Sponsor
- Huajian Future
- Start
- Jul 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of HJ787 in atopic dermatitis (AD), sponsored by Huajian Future. Started Jul 2024; status: active.
02
Drugs
HJ787
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on CTR20242529.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20242529.